EE03823B1 - Piperidiini karboksamiidderivaadid, kompositsioon, vaheühend ja selle valmistamismeetod - Google Patents
Piperidiini karboksamiidderivaadid, kompositsioon, vaheühend ja selle valmistamismeetodInfo
- Publication number
- EE03823B1 EE03823B1 EE9800371A EE9800371A EE03823B1 EE 03823 B1 EE03823 B1 EE 03823B1 EE 9800371 A EE9800371 A EE 9800371A EE 9800371 A EE9800371 A EE 9800371A EE 03823 B1 EE03823 B1 EE 03823B1
- Authority
- EE
- Estonia
- Prior art keywords
- preparation
- composition
- carboxamide derivatives
- piperidine carboxamide
- piperidine
- Prior art date
Links
- JSPCTNUQYWIIOT-UHFFFAOYSA-N piperidine-1-carboxamide Chemical class NC(=O)N1CCCCC1 JSPCTNUQYWIIOT-UHFFFAOYSA-N 0.000 title 1
- 108010073038 Penicillin Amidase Proteins 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/0803—Compounds with Si-C or Si-Si linkages
- C07F7/081—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te
- C07F7/0812—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te comprising a heterocyclic ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/34—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/55—Acids; Esters
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
- C07D223/02—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings
- C07D223/06—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
- C07D317/50—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to atoms of the carbocyclic ring
- C07D317/60—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Diabetes (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Hematology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Hydrogenated Pyridines (AREA)
- Treatment Of Liquids With Adsorbents In General (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US1667596P | 1996-05-01 | 1996-05-01 | |
PCT/US1997/007130 WO1997041102A1 (en) | 1996-05-01 | 1997-04-29 | Carboxamide derivatives of pyrrolidine, piperidine and hexahydroazepine for the treatment of thrombosis disorders |
Publications (2)
Publication Number | Publication Date |
---|---|
EE9800371A EE9800371A (et) | 1999-04-15 |
EE03823B1 true EE03823B1 (et) | 2002-08-15 |
Family
ID=21778348
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EE9800371A EE03823B1 (et) | 1996-05-01 | 1997-04-29 | Piperidiini karboksamiidderivaadid, kompositsioon, vaheühend ja selle valmistamismeetod |
Country Status (26)
Country | Link |
---|---|
US (1) | US6069254A (et) |
EP (2) | EP1988078B1 (et) |
JP (1) | JP4328387B2 (et) |
KR (1) | KR100510854B1 (et) |
CN (1) | CN1286684A (et) |
AT (2) | ATE421952T1 (et) |
AU (1) | AU726594B2 (et) |
BG (1) | BG64276B1 (et) |
BR (1) | BR9710434A (et) |
CA (1) | CA2258701C (et) |
CZ (2) | CZ294094B6 (et) |
DE (2) | DE69739239D1 (et) |
DK (1) | DK0923555T3 (et) |
EE (1) | EE03823B1 (et) |
ES (3) | ES2320316T3 (et) |
GE (1) | GEP20002187B (et) |
HK (1) | HK1041406A1 (et) |
NZ (1) | NZ332585A (et) |
PL (1) | PL190796B1 (et) |
PT (1) | PT923555E (et) |
RU (1) | RU2194038C2 (et) |
SK (1) | SK149798A3 (et) |
TR (1) | TR199802207T2 (et) |
UA (1) | UA70285C2 (et) |
WO (1) | WO1997041102A1 (et) |
YU (1) | YU48698A (et) |
Families Citing this family (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6066651A (en) * | 1997-10-29 | 2000-05-23 | Ortho-Mcneil Pharmaceutical, Inc. | Orally-active nipecotamide glycolamide esters for the treatment of thrombosis disorders |
US6020347A (en) * | 1997-11-18 | 2000-02-01 | Merck & Co., Inc. | 4-substituted-4-piperidine carboxamide derivatives |
WO2000056730A1 (en) | 1999-03-22 | 2000-09-28 | Ortho-Mcneil Pharmaceutical, Inc. | PROCESS FOR PREPARING [S-(R*,S*)] -β -[[[1-[1-OXO-3- (4-PIPERIDINYL) PROPYL] -3-PIPERIDINYL] CARBONYL] AMINO] -3- PYRIDINEPROPANOIC ACID AND DERIVATIVES |
NZ514383A (en) * | 1999-03-22 | 2004-01-30 | Ortho Mcneil Pharm Inc | Process of preparing 3S-3-amino-3-aryl propionic acid and derivatives thereof |
KR20020015031A (ko) * | 1999-03-22 | 2002-02-27 | 오르토-맥네일 파마슈티칼, 인코퍼레이티드 | 3-아미노-3-아릴 프로파노에이트의 합성 |
CZ20011872A3 (cs) * | 1999-09-29 | 2002-03-13 | Ortho-Mcneil Pharmaceutical, Inc. | Isonipekotamidy pro léčbu onemocnění zprostředkovaných integriny |
AUPQ570100A0 (en) * | 2000-02-17 | 2000-03-09 | Fujisawa Pharmaceutical Co., Ltd. | Beta-alanine derivatives and their use as receptor antagonists |
SE0001803D0 (sv) * | 2000-05-16 | 2000-05-16 | Astrazeneca Ab | New compounds i |
DE60208186T2 (de) | 2001-04-09 | 2006-08-24 | Ortho-Mcneil Pharmaceutical Research Inc. | Chinazolin- und chinazolinähnliche verbindungen zur behandlung von integrin-vermittelten erkrankungen |
JP4617449B2 (ja) | 2002-07-11 | 2011-01-26 | ヴィキュロン ファーマシューティカルズ インコーポレイテッド | 抗菌活性を有するn−ヒドロキシアミド誘導体 |
DE10355461A1 (de) * | 2003-11-27 | 2005-06-23 | Bayer Healthcare Ag | Verfahren zur Herstellung einer festen, oral applizierbaren pharmazeutischen Zusammensetzung |
WO2005079863A1 (ja) | 2004-02-25 | 2005-09-01 | Astellas Pharma Inc. | 血栓造影剤 |
RU2393154C2 (ru) * | 2004-03-24 | 2010-06-27 | Йерини Аг | Новые соединения для ингибирования ангиогенеза и их применение |
US7687665B2 (en) | 2004-06-24 | 2010-03-30 | Incyte Corporation | 2-methylprop anamides and their use as pharmaceuticals |
EA200700117A1 (ru) | 2004-06-24 | 2007-06-29 | Инсайт Корпорейшн | N-замещенные пиперидины и их применение в качестве фармацевтических препаратов |
WO2008106202A1 (en) * | 2007-02-27 | 2008-09-04 | Housey Gerard M | Theramutein modulators |
US8207298B2 (en) | 2008-05-01 | 2012-06-26 | Archemix Corp. | Methods of separating biopolymer conjugated molecules from unconjugated molecules |
BR112012011793A2 (pt) | 2009-11-18 | 2019-09-24 | Fab Pharma Sas | "acrilamidas heterocíclicas e seu uso como farmacêuticos" |
WO2013023795A1 (en) * | 2011-08-17 | 2013-02-21 | Piramal Imaging Sa | Compounds for binding to the platelet specific glycoprotein iib/iiia and their use for imaging of thrombi |
CN105189521A (zh) | 2013-02-12 | 2015-12-23 | 拜耳医药股份公司 | 结合至血小板特异性糖蛋白IIb/IIIa的金属螯合化合物 |
MY189670A (en) * | 2015-07-08 | 2022-02-24 | Research & Business Found Sungkyunkwan Univ | Pyrrolidine carboxamido derivatives and methods for preparing and using the same |
EP3759070A4 (en) | 2018-02-28 | 2021-12-08 | Bridge Biotherapeutics, Inc. | WATER-SOLUBLE SALT OF LIPIDATED PEPTIDES AND PROCESS FOR THEIR PRODUCTION AND USE |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3435156A1 (de) * | 1984-09-25 | 1986-04-03 | Boehringer Mannheim Gmbh, 6800 Mannheim | Verfahren zur herstellung der stereoisomeren von 1-amino-alkylphosphonsaeuren oder 1-aminoalkylphosphinsaeuren |
RU2161155C2 (ru) * | 1993-09-22 | 2000-12-27 | Фудзисава Фармасьютикал Ко., Лтд | Производные n-(3-пиперидинилкарбонил)-бета-аланина в качестве антагонистов фактора активации тромбоцитов (фат), способ получения, фармацевтическая композиция и способ лечения |
CA2174516A1 (en) * | 1993-10-19 | 1995-04-27 | Yoshiharu Ikeda | 2,3-diaminopropionic acid derivative |
US5770575A (en) * | 1994-03-16 | 1998-06-23 | Ortho Pharmaceutical Corporation | Nipecotic acid derivatives as antithrombotic compounds |
US5639765A (en) * | 1995-01-17 | 1997-06-17 | G. D. Searle & Co. | Guanidinoalkyl glycine β-amino acids useful for inhibiting bone loss |
CA2215106A1 (en) * | 1995-03-17 | 1996-09-26 | Fujisawa Pharmaceutical Co., Ltd. | N-acylpiperidinylcarbonylaminocarboxylic acids and their use as glycoprotein iib/iiia antagonists and fibrinogen-blood platelets binding inhibitors |
-
1997
- 1997-04-29 EP EP08075675A patent/EP1988078B1/en not_active Expired - Lifetime
- 1997-04-29 CZ CZ20021311A patent/CZ294094B6/cs not_active IP Right Cessation
- 1997-04-29 ES ES01203872T patent/ES2320316T3/es not_active Expired - Lifetime
- 1997-04-29 SK SK1497-98A patent/SK149798A3/sk unknown
- 1997-04-29 JP JP53913497A patent/JP4328387B2/ja not_active Expired - Lifetime
- 1997-04-29 NZ NZ332585A patent/NZ332585A/xx unknown
- 1997-04-29 EE EE9800371A patent/EE03823B1/et not_active IP Right Cessation
- 1997-04-29 BR BR9710434A patent/BR9710434A/pt not_active Application Discontinuation
- 1997-04-29 WO PCT/US1997/007130 patent/WO1997041102A1/en active IP Right Grant
- 1997-04-29 DK DK97922518T patent/DK0923555T3/da active
- 1997-04-29 PL PL329695A patent/PL190796B1/pl unknown
- 1997-04-29 US US08/841,016 patent/US6069254A/en not_active Expired - Lifetime
- 1997-04-29 AU AU28166/97A patent/AU726594B2/en not_active Ceased
- 1997-04-29 DE DE69739239T patent/DE69739239D1/de not_active Expired - Lifetime
- 1997-04-29 CA CA002258701A patent/CA2258701C/en not_active Expired - Lifetime
- 1997-04-29 UA UA98115886A patent/UA70285C2/uk unknown
- 1997-04-29 GE GEAP19974552A patent/GEP20002187B/en unknown
- 1997-04-29 ES ES08075675T patent/ES2396725T3/es not_active Expired - Lifetime
- 1997-04-29 ES ES97922518T patent/ES2243996T3/es not_active Expired - Lifetime
- 1997-04-29 PT PT97922518T patent/PT923555E/pt unknown
- 1997-04-29 AT AT01203872T patent/ATE421952T1/de not_active IP Right Cessation
- 1997-04-29 TR TR1998/02207T patent/TR199802207T2/xx unknown
- 1997-04-29 DE DE69733565T patent/DE69733565T2/de not_active Expired - Lifetime
- 1997-04-29 CN CN97194303A patent/CN1286684A/zh active Pending
- 1997-04-29 RU RU98121706/04A patent/RU2194038C2/ru not_active IP Right Cessation
- 1997-04-29 AT AT97922518T patent/ATE297894T1/de not_active IP Right Cessation
- 1997-04-29 CZ CZ19983488A patent/CZ293912B6/cs not_active IP Right Cessation
- 1997-04-29 EP EP97922518A patent/EP0923555B1/en not_active Expired - Lifetime
- 1997-04-29 KR KR1019980708783A patent/KR100510854B1/ko not_active IP Right Cessation
-
1998
- 1998-10-30 YU YU48698A patent/YU48698A/sh unknown
- 1998-11-30 BG BG102966A patent/BG64276B1/bg unknown
-
2002
- 2002-04-23 HK HK02103047.5A patent/HK1041406A1/zh unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EE03823B1 (et) | Piperidiini karboksamiidderivaadid, kompositsioon, vaheühend ja selle valmistamismeetod | |
DK0595610T3 (da) | Benzokondenserede lactamer | |
PT923554E (pt) | N-benzilpiperidina e derivados tetrahidropiridina | |
FI914905A (fi) | Menetelmä uusien terapeuttisesti käyttökelpoisten merkaptoasetyyliamidopyrrolo- ja -pyridobentsatsepiinijohdannaisten valmistamiseksi | |
FI20000353A (fi) | 3,4,4-trisubstituoidun piperidinyyli-N-alkyylikarboksylaatin valmistus ja välituotteet | |
PT1004578E (pt) | Derivados hidroxamida do acido 5-oxo-pirrolidino-2-carboxilico | |
EA199700124A1 (ru) | Производные гуанина | |
KR970706824A (ko) | 붕산 에스테르 및 붕산 화합물, 이의 합성 방법 및 용도(boronic ester and acid compounds, synthesis and uses) | |
ES2131463B1 (es) | Derivados de ciclopropilglicina con propiedades farmaceuticas. | |
ATE179169T1 (de) | Prostaglandinanaloge | |
EA200000094A1 (ru) | Способ получения замещенного пергидроизоиндола | |
FI955498A0 (fi) | Nipekotiinihappojohdannaisia hyytymistä estävinä aineina | |
PT965588E (pt) | Processo de preparacao de derivados de 4-fenil-1,2,3,6-tetra-hidropiridina e os produtos intermediarios utilizados no processo | |
SE8900813D0 (sv) | Foerfarande foer framstaellning av dihydropyridinderivat | |
FI103885B1 (fi) | Menetelmä terapeuttisesti aktiivisten 1-bentsyyli-4-fenyylipiperatsiinijohdannaisten valmistamiseksi ja välituotteina käyttökelpoisia yhdisteitä | |
ES2153902T3 (es) | Derivado ester de acido guanidinometilciclohexanocarboxilico. | |
NO995132D0 (no) | Fremgangsmåte for reduksjon av fibrinogen | |
DZ1704A1 (fr) | Dérivés de la n-(phényléthyl-b-ol) amine ainsi queleur procédé de préparation. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
KB4A | Valid patent at the end of a year |
Effective date: 20021231 |
|
KB4A | Valid patent at the end of a year |
Effective date: 20031231 |
|
KB4A | Valid patent at the end of a year |
Effective date: 20041231 |
|
KB4A | Valid patent at the end of a year |
Effective date: 20051231 |
|
KB4A | Valid patent at the end of a year |
Effective date: 20061231 |
|
KB4A | Valid patent at the end of a year |
Effective date: 20071231 |
|
KB4A | Valid patent at the end of a year |
Effective date: 20081231 |
|
MM4A | Lapsed by not paying the annual fees |
Effective date: 20090429 |